Home/Pipeline/TetraLink SI Joint Fusion System

TetraLink SI Joint Fusion System

Sacroiliac Joint Dysfunction

CommercialActive

Key Facts

Indication
Sacroiliac Joint Dysfunction
Phase
Commercial
Status
Active
Company

About SI-BONE

SI-BONE's mission is to improve the quality of life for patients suffering from SI joint dysfunction through innovative, minimally invasive surgical solutions. The company has established itself as the market leader with its FDA-cleared iFuse Implant System, backed by a deep clinical evidence portfolio including multiple randomized controlled trials. Its strategy focuses on expanding physician training, penetrating the large, under-addressed market of chronic low back pain, and leveraging its platform into adjacent applications like spinopelvic fixation and pelvic trauma.

View full company profile

Other Sacroiliac Joint Dysfunction Drugs

DrugCompanyPhase
iFuse Implant SystemSI-BONECommercial
iFuse 3DSI-BONECommercial